Shareholding disclosure

Lazard Asset Management LLC

Declared position

Threshold

Fell below threshold

Timeline

Published

30.01.2014

Transaction

24.01.2014

Transfer date

24.01.2014

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAE1T00022

Beneficial owner

Lazard Asset Management LLC

Declared address

Lazard Asset Management LLC, New York, NY 10112

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Lazard Asset Management LLC

BB Biotech AG30.01.2014TAE1T00022

Disclosure summary

Lazard Asset Management LLC disclosed a holding in BB Biotech AG that fell below the publication threshold, published by SIX Exchange Regulation on 30.01.2014, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Lazard Asset Management LLC disclosed a holding in BB Biotech AG, published on 30.01.2014.

Publication date30.01.2014

Transaction date24.01.2014

Transfer date24.01.2014

Issuing companyBB Biotech AG

Beneficial ownerLazard Asset Management LLC

Declared addressLazard Asset Management LLC, New York, NY 10112

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAE1T00022

Source: SIX Exchange Regulation · Publication date: 30.01.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open